The 13th St Gallen International breast cancer conference (2013) Expert Panel recommends the use of four biomarkers for molecular subtyping of breast cancer:
Based on recommendations of the St
Gallen Consensus group, these markers
are used to identify 5 distinct subtypes:
Each of these subtypes is associated with a clear therapy recommendation and distinct characteristics of the patient’s prognosis.